A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine
Clinical trial NCT01265914 · COMPLETED
Trial details
- NCT number
- NCT01265914
- Sponsor
- Immune Targeting Systems Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-03-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.